← Back to all trials
Completed
NCT05614791
Evaluation of Pediatric Measles Cases in 2019: Single-Center Experience
Conditions: Measles
Sex: All
Ages: 1 Month – 18 Years
Enrollment: 40
Sponsor: Marmara University
Location: Turkey
Summary
Measles, can be prevented and eliminated by vaccination, is a highly contagious viral disease that can lead to serious complications, disability, and death.
As a result of the World Health Organization (WHO) and United Nations International Children's Emergency Fund (UNICEF) strategic plans, the annual global incidence of measles decreased by 75% over the period 2000-2015, and the estimated global mortality rate fell by 73%.
For the current 2019 period, the European and the Eastern Mediterranean Region has recorded respectively more than two-fold and 1.5-fold increase in reported measles cases.
As it is known, no specific antiviral treatment exists for the measles virus therefore, vaccination is still the most effective method of preventing disease.The aim of this study was to evaluate the measles cases in districts where the refugees live quite intensely.
Eligibility Criteria
Inclusion Criteria:The suspicious case of measlesMeasles/Rubella Case Notification and Laboratory request and result form and Measles/ Rubella Case Study form must be filledAccept the informed consent formPositive Measles Ig M and Measles Ig G laboratory testExclusion Criteria:Rejected the informed consent form
Source: ClinicalTrials.gov (NCT05614791). StuddyBuddy aggregates publicly available trial information.